Remove 2014 Remove Compliance Remove Oil Remove Vaping
article thumbnail

Perkins Coie: Prop 65 Plaintiffs Set Their Sights on Cannabis Industry

Cannabis Law Report

Over the past ten years, Proposition 65 plaintiffs have turned their sights on the cannabis industry, issuing over 200 notices of violation for a variety of chemicals in products from smokable marijuana flower to CBD oil, and vape pens to hemp-based personal care products.

Oil 52
article thumbnail

Prop 65 Plaintiffs Set Their Sights on Cannabis Industry

Cannabis Law Report

Over the past ten years, Proposition 65 plaintiffs have turned their sights on the cannabis industry, issuing over 200 notices of violation for a variety of chemicals in products from smokable marijuana flower to CBD oil, and vape pens to hemp-based personal care products.

Oil 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Wait a Minute Mr. Postman: USPS Nixes Cannabis and Hemp ENDS in the Mail

Canna Law Blog

Then, in 2019, we wrote about the Business Mail Acceptance (“BMA”) internal advisory on “ Acceptance Criteria for Cannabidiol (CBD) Oil and Products Containing CBD.” Notably, PACT has severe penalties for non-compliance, including prison time. Code Section §1716E(b).

Hemp 87
article thumbnail

New York Cannabis Companies Sidestep Flower Ban With Ground Flower Refills

SpeedWeed

Flower is legally available to New Yorkers with medical cards, so long as it’s ground up, ostensibly for vaping. When New York started its medical program in 2014, Gov. She said Curaleaf worked with the DOH to “bring these products into compliance” and resumed sales. Are they required by state law to vape the refills?

Vaping 52
article thumbnail

Curaleaf shares down 8% after FDA sends warning letter over CBD health claims

Cannabis Law Report

FDA has determined that your “CBD Lotion,” “CBD Pain-Relief Patch,” “CBD Tincture,” and “CBD Disposable Vape Pen” products are unapproved new drugs sold in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act), 21 U.S.C. 355(a) and 331(d). Unapproved New and Misbranded Human Drug Products.

CBD 51
article thumbnail

Cannabis Education with Canada’s Newcomers

Cannabis Law Report

Next, Ziad El Shourbagy, Community Engagement Specialist at Tweed, headquartered in Smith Falls since 2014 and belonging to parent holding company Canopy Growth (TSX: WEED), launched into a deeply informative “Cannabis 101” styled two-hour presentation on the Fundamentals of Cannabis and Responsible Consumption.

article thumbnail

Cannabis Industry Leaders Speak With CLR on Current Delta 8 Issues In The Industry

Cannabis Law Report

His first-hand experience with therapeutic hemp oil products as nutritional supplements led him to Medical Marijuana Inc. As a graduate student, he received the IPMI Richard Rubin Memorial Scholarship in 2014 for his research in precious metals. To InfiniteCAL, selling Delta 8-THC products in licensed dispensaries makes the most sense.